Australian government might subsidize Alimta for mesothelioma
The Sydney Morning Herald reports that Australia’s Pharmaceutical Benefits Scheme might add Alimta to the list of drugs eligible for coverage. Only half of Australians with mesothelioma have been able to get access because of state government subsidy schemes and coverage of the workplace compensation. There has been some controversy because Alimta was more readily available for lung cancer patients than for mesothelioma patients.
